Onderneming Syros Pharmaceuticals, Inc.
Aandelen
SYRS
US87184Q2066
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
5,04 USD | -1,18% | +11,01% | -35,30% |
Vakgebied
Aantal werknemers: 68
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Gene Control Medicines
100,0
%
| 15 | 100,0 % | 10 | 100,0 % | -33,23% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 15 | 100,0 % | 10 | 100,0 % | -33,23% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Conley Chee
CEO | Chief Executive Officer | 54 | 27-09-21 |
Nancy Simonian
CEO | Chief Executive Officer | 63 | 01-11-12 |
Jason Haas
DFI | Director of Finance/CFO | 56 | 12-10-21 |
David Roth
CTO | Chief Tech/Sci/R&D Officer | 61 | 07-12-15 |
Gerald Quirk
ADM | Chief Administrative Officer | 56 | 01-09-16 |
Karen Hunady
IRC | Investor Relations Contact | - | 01-10-22 |
Lisa Roberts
HRO | Human Resources Officer | - | 01-01-12 |
Kristin Stephens
PRN | Corporate Officer/Principal | 51 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 56 | 12-06-17 | |
Tim Tyson
BRD | Director/Board Member | 71 | 16-09-22 |
Marsha Fanucci
BRD | Director/Board Member | 70 | 19-10-15 |
Deborah Dunsire
BRD | Director/Board Member | 61 | 09-09-21 |
Peter Wirth
CHM | Chairman | 73 | 30-01-17 |
Nancy Simonian
CEO | Chief Executive Officer | 63 | 01-11-12 |
Richard Young
FOU | Founder | 70 | 09-11-11 |
S. Gail Eckhardt
BRD | Director/Board Member | 66 | 08-09-20 |
Andrew Oh
BRD | Director/Board Member | 53 | 16-09-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 26 728 337 | 26 442 318 ( 98,93 %) | 0 | 98,93 % |
Bedrijfsgegevens
Syros Pharmaceuticals, Inc.
35 CambridgePark Drive 4th floor
02140-2325, Cambridge
+617 744 1340
http://www.syros.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-35,30% | 135 mln. | |
+1,51% | 42,75 mld. | |
+49,22% | 41,61 mld. | |
+8,57% | 41,34 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |
- Beurs
- Aandelen
- Koers SYRS
- Onderneming Syros Pharmaceuticals, Inc.